Abstract:There is an urgent need to better understand the pathophysiology of Coronavirus disease 2019 (COVID-19), the global pandemic caused by SARS-CoV-2, which has infected more than three million people worldwide<a href="/articles/s41591-020-0944-y#ref-CR1">1</a>. Approximately 20% of patients with COVID-19 develop severe disease and 5% of patients require intensive care<a href="/articles/s41591-020-0944-y#ref-CR2">2</a>. Severe disease has been associated with changes in peripheral immune activity, including increased levels of pro-inflammatory cytokines<a href="/articles/s41591-020-0944-y#ref-CR3">3</a>,<a href="/articles/s41591-020-0944-y#ref-CR4">4</a> that may be produced by a subset of inflammatory monocytes<a href="/articles/s41591-020-0944-y#ref-CR5">5</a>,<a href="/articles/s41591-020-0944-y#ref-CR6">6</a>, lymphopenia<a href="/articles/s41591-020-0944-y#ref-CR7">7</a>,<a href="/articles/s41591-020-0944-y#ref-CR8">8</a> and T cell exhaustion<a href="/articles/s41591-020-0944-y#ref-CR9">9</a>,<a href="/articles/s41591-020-0944-y#ref-CR10">10</a>. To elucidate pathways in peripheral immune cells that might lead to immunopathology or protective immunity in severe COVID-19, we applied single-cell RNA sequencing (scRNA-seq) to profile peripheral blood mononuclear cells (PBMCs) from seven patients hospitalized for COVID-19, four of whom had acute respiratory distress syndrome, and six healthy controls. We identify reconfiguration of peripheral immune cell phenotype in COVID-19, including a heterogeneous interferon-stimulated gene signature, HLA class II downregulation and a developing neutrophil population that appears closely related to plasmablasts appearing in patients with acute respiratory failure requiring mechanical ventilation. Importantly, we found that peripheral monocytes and lymphocytes do not express substantial amounts of pro-inflammatory cytokines. Collectively, we provide a cell atlas of the peripheral immune response to severe COVID-19.

A single-cell atlas reveals shared and distinct immune responses and metabolic profiles in SARS-CoV-2 and HIV-1 infections

Overly Exuberant Innate Immune Response to SARS-CoV-2 Infection

The single-cell landscape of immunological responses of CD4+ T cells in HIV versus severe acute respiratory syndrome coronavirus 2

Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes

Meta-analysis reveals consistent immune response patterns in COVID-19 infected patients at single-cell resolution

Single-cell landscape of immunological responses in patients with COVID-19

COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas

SARS-CoV-2 and HIV-1: So Different yet so Alike . Immune Response at the Cellular and Molecular Level

Identification of Distinct Immune Cell Subsets Associated With Asymptomatic Infection, Disease Severity, and Viral Persistence in COVID-19 Patients

Single-cell landscape of immunological responses in COVID-19 patients

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients

Single-cell atlas of a non-human primate reveals new pathogenic mechanisms of COVID-19

Single‐cell transcriptomic atlas reveals distinct immunological responses between COVID‐19 vaccine and natural SARS‐CoV‐2 infection

Dissecting human population variation in single-cell responses to SARS-CoV-2

Single-cell atlas of a non-human primate reveals new pathogenic 1 mechanisms of COVID-19 2

Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System

Blood single cell immune profiling reveals the interferon-MAPK pathway mediated adaptive immune response for COVID-19

Single Cell and Immune Repertoire Profiling of COVID-19 Patients Reveal Novel Therapeutic Candidates

Integration and Reanalysis of Four RNA-Seq Datasets Including BALF, Nasopharyngeal Swabs, Lung Biopsy, and Mouse Models Reveals Common Immune Features of COVID-19.

Large-scale single-cell analysis reveals critical immune characteristics of COVID-19 patients